Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:07:18 05/07/2024 pm IST			5-day change	1st Jan Change
26.16 ^EUR	-0.15%		-0.82%	-22.20%

02/07	Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	CI
28/06	Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	DP

Bayer Aktiengesellschaft acquired Targenomix GmbH.

November 10, 2022

Bayer Aktiengesellschaft (XTRA:BAYN) acquired Targenomix GmbH on November 10, 2022.

Bayer Aktiengesellschaft (XTRA:BAYN) completed the acquisition of Targenomix GmbH on November 10, 2022.

Latest news about Bayer AG

Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	02/07	CI
Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading)	28/06	DP
Chemicals collective agreement: Bonus days for union members	27/06	DP
German chemical sector employers, union agree 6.85% pay hike over 20 months	27/06	RE
Chemicals collective bargaining agreement: extra day for trade unionists	27/06	DP
The same old winners	27/06
Bayer's pharmaceuticals division plans to cut further managerial jobs	27/06	RE
Bayer's Pharmaceuticals Unit to Cut More Managerial Jobs Amid Reorganization	27/06	MT
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia	27/06	RE
Global markets live: Bayer, FedEx, Nvidia, KKR, Verizon...	26/06
Dpa-AFX Overview: COMPANIES from 26.06.2024 - 15:15	26/06	DP
Anton switch to Dortmund perfect? Voller rows back	26/06	DP
Bayer CEO - Making faster progress with restructuring	26/06	RE
Chemical industry wage partners seek solution before the end of the peace period	26/06	DP
Bayer: patients recruited for phase 2 Parkinson's trial	25/06	CF
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets	24/06	CI
Global markets live: Vodafone, Bayer, Apple, Microsoft, Qualcomm...	19/06
Bayer's Crop Science Business Developing AI to Kill Weeds	19/06	MT
Bayer looks to AI to combat herbicide resistance faster	19/06	RE
Transcript : Bayer Aktiengesellschaft - Special Call	19/06
New Bayer short corn variety stands up to high winds, but not over 100 mph	19/06	RE
South Africa finds high prices, lack of competition in its fresh produce market	18/06	RE
Economics Minister Habeck travels to China without prominent company representatives	18/06	RE
Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma	18/06	MT
Nationwide actions - Trade union increases pressure in chemical industry collective bargaining round	18/06	DP

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Sector

Pharmaceuticals

Calendar

06/08/2024 - Q2 2024 Earnings Release

Related indices

Euro STOXX 50 Index , STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

BAYER : As soft as anticipated

May 14, 2024 at 11:42 pm IST

Bayer AG: Not out of the woods yet

March 06, 2024 at 09:16 pm IST

More Strategies

Ratings for Bayer AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.16 EUR

Average target price

36.18 EUR

Spread / Average Target

+38.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAYER AG	-22.20%	2.78TCr
ELI LILLY AND COMPANY	+56.89%	81TCr
NOVO NORDISK A/S	+39.52%	62TCr
JOHNSON & JOHNSON	-6.55%	35TCr
ABBVIE INC.	+7.92%	29TCr
ASTRAZENECA PLC	+13.74%	24TCr
NOVARTIS AG	+13.83%	22TCr
ROCHE HOLDING AG	-0.49%	22TCr
AMGEN INC.	+7.94%	17TCr
PFIZER, INC.	-2.57%	16TCr

Other Pharmaceuticals

Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Bayer Aktiengesellschaft acquired Targenomix GmbH.

Latest news about Bayer AG

Chart Bayer AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Bayer AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals